1DD-LSD

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
1DD-LSD
Clinical data
Other names1-Dodecanoyl-LSD; SYN-L-004
Identifiers
  • (6aR,9R)-N,N-diethyl-6-methyl-4-dodecanoyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
CAS Number
PubChem CID
E number{{#property:P628}}
CompTox Dashboard (EPA)
  • {{#property:P3117}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC32H47N3O2
Molar mass505.747 g·mol−1
3D model (JSmol)
  • CCCCCCCCCCCC(=O)N1C=C2C[C@@H]3C(=C[C@H](CN3C)C(=O)N(CC)CC)C4=C2C1=CC=C4
  • InChI=1S/C32H47N3O2/c1-5-8-9-10-11-12-13-14-15-19-30(36)35-23-24-21-29-27(26-17-16-18-28(35)31(24)26)20-25(22-33(29)4)32(37)34(6-2)7-3/h16-18,20,23,25,29H,5-15,19,21-22H2,1-4H3/t25-,29-/m1/s1
  • Key:CEPIQEJKLWHRTL-VAVYLYDRSA-N

1DD-LSD, also known as 1-dodecanoyl-LSD or as SYN-L-004, is an acylated derivative of lysergic acid diethylamide (LSD). In animal studies, it produces a weak head-twitch response but with 27x lower potency than LSD itself. It is being researched as a potential slow-onset, long lasting prodrug for LSD which is expected to have reduced psychoactive effects.[1][2]

Use and effects

[edit | edit source]

Interactions

[edit | edit source]

Chemistry

[edit | edit source]

Analogues

[edit | edit source]

Analogues of 1DD-LSD include ALD-52 (1A-LSD), 1P-LSD, 1B-LSD, 1H-LSD, and 1V-LSD, among others.

See also

[edit | edit source]

References

[edit | edit source]
  1. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  2. ^ WO 2024/028495, Stratford A, Williamson JP, "Prodrugs of Substituted Ergolines", published Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value)., assigned to Synex Holdings BV 
[edit | edit source]